grant

NOVEL cGMP-BASED THERAPIES PREVENT LEFT VENTRICULAR REMODELLING [ 2008 - 2010 ]

Also known as: New drug strategies to prevent abnormal cardiac growth and heart failure

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/472642]

Researchers: Prof Rebecca Ritchie (Principal investigator) ,  Dr Barbara Kemp-Harper Prof John Horowitz

Brief description Over 300,000 Australians are affected by heart failure. Current drugs for cardiac remodelling (the decline in heart pumping function and changed structure that precede heart failure) slow but not reverse disease progression. We have identified a new, nitrovasodilator-based therapy superior to those currently available. We propose it represents a more effective treatment for reversing abnormalities in both structure and function in the remodelled heart, preventing or delaying heart failure.

Funding Amount $AUD 533,433.08

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Identifiers
Viewed: [[ro.stat.viewed]]